Introduction
In the fast-growing landscape of cancer treatment, the paradigm is shifting towards personalized medicine—a tailored approach that recognizes the unique genetic and clinical characteristics of cancer patients. At the core of this paradigm shift are precision clinical trials that drive advancements in personalized cancer therapeutics. By matching patients
